An earlier study showed that CD137-CD137L (4-1BB-4-1BBL) interaction impairs NK cell anti-tumor activity in humans via induction of IL-10 and TNF release from AML cells, which allowed AML cells to evade being eliminated by NK cells [29]. This evidence concerns the gene TNFSF9 and acute myeloid leukemia.